Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2005-07-26
2005-07-26
Jastrzab, Jeffrey R. (Department: 3762)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S058000, C604S891100
Reexamination Certificate
active
06922590
ABSTRACT:
Systems and methods for introducing one or more stimulating drugs and/or applying electrical stimulation to the brain to at least treat or prevent diabetes uses at least one system control unit (SCU) producing electrical pulses delivered via electrodes implanted in the brain and/or producing drug infusion pulses, wherein the stimulating drug(s) are delivered to targeted areas in the brain.
REFERENCES:
patent: 4646744 (1987-03-01), Capel
patent: 5188104 (1993-02-01), Wernicke et al.
patent: 5193539 (1993-03-01), Schulman et al.
patent: 5193540 (1993-03-01), Schulman et al.
patent: 5231988 (1993-08-01), Wernicke et al.
patent: 5263480 (1993-11-01), Wernicke et al.
patent: 5312439 (1994-05-01), Loeb
patent: 5324316 (1994-06-01), Schulman et al.
patent: 5405367 (1995-04-01), Schulman et al.
patent: 5487739 (1996-01-01), Aebischer et al.
patent: 5496369 (1996-03-01), Howard, III
patent: 5540730 (1996-07-01), Terry, Jr. et al.
patent: 5540734 (1996-07-01), Zabara
patent: 5589183 (1996-12-01), Jannetta
patent: 5597797 (1997-01-01), Clark
patent: 5697975 (1997-12-01), Howard, III et al.
patent: 5741211 (1998-04-01), Renirie et al.
patent: 5782798 (1998-07-01), Rise
patent: 5843093 (1998-12-01), Howard, III
patent: 5919216 (1999-07-01), Houben et al.
patent: 5989920 (1999-11-01), Gerald et al.
patent: 6006124 (1999-12-01), Fischell et al.
patent: 6016449 (2000-01-01), Fischell et al.
patent: 6051017 (2000-04-01), Loeb et al.
patent: 6093167 (2000-07-01), Houben et al.
patent: 6094598 (2000-07-01), Elsberry et al.
patent: 6129685 (2000-10-01), Howard, III
patent: 6171239 (2001-01-01), Humphrey
patent: 6269270 (2001-07-01), Boveja
patent: 6284729 (2001-09-01), Bernfield et al.
patent: 6353762 (2002-03-01), Baudino et al.
patent: 6374140 (2002-04-01), Rise
patent: 6415184 (2002-07-01), Ishikawa et al.
patent: WO-92/13592 (1992-08-01), None
patent: WO-93/02743 (1993-02-01), None
patent: WO-98/37926 (1998-09-01), None
patent: WO-98/43700 (1998-10-01), None
patent: WO-98/43701 (1998-10-01), None
patent: WO-01/60450 (2001-08-01), None
Ahren, et al., “The Mechanism of Vagal Nerve Stimulation of Glucagon and Insulin Secretion in the Dog”, Endocrinology, vol. 118, No. 4, (Apr. 1986), pp. 1551-1557.
Ahren, et al., “Sympathetic Nerve Stimulation Versus Pancreatic Norepinephrine Infusion in the Dog: 1. Effects on Basal Release of Insulin and Glucagon”, Endocrinology, vol. 121, No. 1, (Jul. 1987), pp. 323-331.
Bereiter, et al., “CNS Modulation of Pancreatic Endocrine Function Multiple Modes of Expression”, Diabetologia, Suppl. 20, (Mar. 1981), pp. 417-425.
Berthoud, et al., “Characteristics of Gastric and Pancreatic Responses to Vagal Stimulation with Varied Frequencies: Evidence for Different Fiber Calibers?”, Journal of the Autonomic Nervous System, vol. 19, No. 1, (Apr. 1987), pp. 77-84.
Berthoud, et al., “Localization of Vagal Preganglionics that Stimulate Insulin and Glucagon Secretion”, AM J Physiol, vol. 258, No. 1 Part 2, (Jan. 1990), pp. R160-R168.
Bluher, et al. “Improvement of Insulin Sensitivity After Adrenalectomy in Patients with Pheochromocytoma”, Diabetes Care, vol. 23, No. 10, (Oct. 1, 2000), pp. 1591-1592.
Brobeck, Jr., “Mechanism of Development of Obesity in Animals with Hypothalamic Lesions”, Physiol Rev. vol. 26, (1946), pp. 541-559.
Broglio, et al., “Ghrelin, a Natural GH Secretagogue Produced by the Stomach, Induces Hyperglycemia and Reduces Insulin Secretion in Humans”, The Journal of Clinical Endocrinology & Metabolism, vol. 86, No. 10, (Oct. 2001), pp. 5083-5086.
Cameron, et al., “Micromodular Implants to Provide Electrical Stimulation of Paralyzed Muscles and Limbs”, IEEE Transactions on Biomedical Engineering, vol. 44, No. 9, (Sep. 1997), pp. 781-790.
Davalli, et al., “Abnormal Sensitivity to Glucose of Human Islets Cultured in a High Glucose Medium: Partial Reversibility After an Additional Culture in a Normal Glucose Medium”, Journal of Clinical Endocrinology and Metabolism, vol. 72, (1991), pp. 202-208.
DeNicola, et al., “Abnormal Regulation of Adrenal Function in Rats with Streptozotocin Diabetes”, Horm Metab Res, vol. 9, (1977), pp. 469-473.
Dhillo, et al., “Hypothalami Peptides as Drug Targets for Obesity”, Current Opinion in Pharmacology, vol. 1, No. 6, (2001), pp. 651-655.
Frankish, et al., “Neuropeptide Y, the Hypothalamus, and Diabetes: Insights Into the Central Control of Metabolism”, Peptides, vol. 16, No. 4, (1995), pp. 757-771.
Gardemann, et al., “Reinnervation of Pancreatic Islets and Regulation of Insulin Secretion by Hepatic Sympathetic Nerves After Intrportal Transplantation of Islets Into Livers of Diabetic Rats”, Experimental and Clinical Endocrinology and Diabetes, vol. 103, Suppl. 2, (1995), pp. 107-111.
Holst, et al., “Nervous Control of Pancreatic Endocrine Secretion in Pigs. I. Insulin and Glucagon Responses to Electrical Stimulation of the Vagus Nerves”, Acta Physiol Scand, vol. 111, No. 1, (Jan. 1981), pp. 1-7.
Hyde, et al., “Effects of Area Postrema Caudal Medial Nucleus of Solitary Tract Lesions on Food Intake and Body Weight”, AM J Physiol, vol. 244, (1983), pp. R577-R587.
Ionescu, et al., “Increase in Plasma Insulin Levels in Response to Electrical Stimulation of the Dorsal Motor Nucleus of the Vagus Nerve”, Endocrinology, vol. 112, No. 3, (Mar. 1983), pp. 904-910.
Jonkers, et al., “Influence of Cell Number on the Characteristics and Synchrony of Ca2+ Oscillations in Clusters on Mouse Pancreatic Islet Cells”, Journal of Physiology, vol. 520, Part 3, (Nov. 1999), pp. 839-849.
Kakizaki, et al., “Neural Regulation of Auto-Grafted Islets of Langerhans”, Nippon Geka Gakkai Zasshi, vol. 89, No. 3, (Mar. 1988), pp. 394-397.
Kakizaki, et al., “Neural Regulation of Heterotopic Islets of Langerhans”, Surgery, vol. 100, No. 6, (Dec. 1986), pp. 997-1002.
Kurose, et al., “Glucagon, Insulin and Somatostatin Secretion in Response to Sympathetic Neural Activation in Streptozotocin0induced Diabetic Rats. A Study with the Isolated Perfused Rat Pancreas in Vitro”, Diabetologia, vol. 35, No. 11, (Nov. 1992), pp. 1035-1041.
Kurose, et al., “Mechanism of Sympathetic Neural Regulation of Insulin, Somatostatin, and Glucagon Secretion”, Am J Physiol, vol. 258, No. 1 part 1, (Jan. 1990), pp. E220-E227.
Lorrain, et al., “Adrenergic and Nonadrenergic Cotransmitters Inhibit Insulin, Secretion During Sympathetic Stimulation in Dogs”, AM J Physiol, vol. 263, No. 1 Part 1, (Jul. 1992), pp. E72-E78.
Mayfield, et al., “A Role for the Agouti-Related Protein Promoter in Obesity and Type 2 Diabetes”, Biochemical and Biophysical Research Communications, vol. 287, No. 2, (Sep. 21, 2001), pp. 568-573.
Minami, et al., “Electrophysiological Properties and Glucose Responsiveness of Guinea-Pig Ventromedial Hypothalamic Neurons in Vitro”, J. Physiol, vol. 380, (1986), pp. 127-143.
Misler, et al., “Electrophysiology of Stimulus-Secretion Coupling in Human Beta-Cells”, Diabetes, vol. 41, No. 10, (Oct. 1992), pp. 1221-1228.
Mondal, et al., “Orexins (hypocretins): Novel Hypothalami Peptides with Divergent Functions”, Biochem Cell Biol, vol. 78, (2000), pp. 299-305.
Nakazato, et al., “A Role for Ghrelin in the Central Regulation of Feeding”, Nature, vol. 409, No. 6817, (Jan. 11, 2001), pp. 194-198.
Nishi, et al., “Vagal Regulation of Insulin, Glucagon, and Somatostatin Secretion in Vitro in the Rat”, J Clin Invest, vol. 79, No. 4, (Apr. 1987), pp. 1191-1196.
Oomura, et al., “Glucose and Osmosensitive Neurons of the Rat Hypothalamus”, Nature, vol. 222, (1969), pp. 282-284.
Perkins, et al., “Activation of Brown Adipose Tissue Thermogenesis by the Ventromedial Hypothalamus”, Nature, vol. 289, (Jan. 1981), pp. 401-402.
Pierroz, et al., “Chronic Administrat
Advanced Bionics Corporation
Jastrzab Jeffrey R.
Laura Haburay Bishop
LandOfFree
Systems and methods for treatment of diabetes by electrical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems and methods for treatment of diabetes by electrical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems and methods for treatment of diabetes by electrical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3372752